As of 2024-12-14, the Relative Valuation of Xlife Sciences AG (XLS.SW) is 102.74 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 26.00 CHF, the upside of Xlife Sciences AG based on Relative Valuation is 295.1%.
The range of the Relative Valuation is 56.61 - 160.52 CHF.
| Range | Selected | |
| Trailing P/E multiples | 35.1x - 43.4x | 39.2x |
| Forward P/E multiples | 39.0x - 44.1x | 41.6x |
| Fair Price | 56.61 - 160.52 | 102.74 |
| Upside | 117.7% - 517.4% | 295.1% |
| Date | P/E |
| 2024-11-22 | 7.87 |
| 2024-11-21 | 7.81 |
| 2024-11-20 | 7.22 |
| 2024-11-19 | 7.03 |
| 2024-11-18 | 7.03 |
| 2024-11-15 | 7.73 |
| 2024-11-14 | 7.57 |
| 2024-11-13 | 7.62 |
| 2024-11-12 | 7.73 |
| 2024-11-11 | 7.25 |
| 2024-11-08 | 6.49 |
| 2024-11-07 | 6.30 |
| 2024-11-06 | 6.54 |
| 2024-11-05 | 6.54 |
| 2024-11-04 | 6.54 |
| 2024-11-01 | 6.46 |
| 2024-10-31 | 6.73 |
| 2024-10-30 | 6.62 |
| 2024-10-29 | 6.71 |
| 2024-10-28 | 6.79 |
| 2024-10-25 | 6.95 |
| 2024-10-24 | 6.87 |
| 2024-10-23 | 6.79 |
| 2024-10-22 | 6.92 |
| 2024-10-21 | 7.06 |
| 2024-10-18 | 7.41 |
| 2024-10-17 | 7.44 |
| 2024-10-16 | 7.44 |
| 2024-10-15 | 7.16 |
| 2024-10-14 | 7.03 |
| 2024-10-11 | 6.76 |
| 2024-10-10 | 6.76 |
| 2024-10-09 | 6.79 |
| 2024-10-08 | 7.22 |
| 2024-10-07 | 7.30 |
| 2024-10-04 | 7.38 |
| 2024-10-03 | 7.87 |
| 2024-10-02 | 7.84 |
| 2024-10-01 | 7.89 |
| 2024-09-30 | 8.33 |
| 2024-09-27 | 9.03 |
| 2024-09-26 | 8.33 |
| 2024-09-25 | 8.11 |
| 2024-09-24 | 8.71 |
| 2024-09-23 | 8.17 |
| 2024-09-20 | 8.90 |
| 2024-09-19 | 8.76 |
| 2024-09-18 | 8.92 |
| 2024-09-17 | 8.19 |
| 2024-09-16 | 7.71 |